Nursing · Independent exam preparation
Dermatology Nurse Certified (DNC) Examination Study Guide
Practise lesion triage, procedure safety, phototherapy monitoring and patient teaching for the RN Dermatology Nurse Certified examination across four domains.
By CertMedbry · Updated 28 October 2026
Practise recognizing dangerous eruptions, interpreting treatment responses, protecting patients during procedures and translating dermatology plans into usable home care. This selective guide develops 60 clinical concepts across the four DNC nursing objectives. The official examination outline and Patient Problem List define the full scope, including conditions and procedures beyond these examples. These independently authored learning materials support preparation for the Dermatology Nursing Certification Board's registered nurse credential.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which credential and eligibility pathway does this guide cover?
The pathway is Dermatology Nurse Certified (DNC), awarded by the Dermatology Nursing Certification Board. The official DNC page specifies a current unrestricted RN license in the United States or Canada, at least two years of dermatology nursing experience as an RN, and at least 2,000 dermatology nursing work hours within the preceding two years. This is an RN examination, separate from DCNP certification.
DNC Certification — Dermatology Nurses’ Association · DNC: Dermatology Nurse Certified — C-NET
How many questions are there, and how long is the examination?
The examination consists of 175 multiple-choice items and is approximately four hours long. Items are written within the framework of the nursing process.
DNC Certification — Dermatology Nurses’ Association · Frequently Asked Questions — Dermatology Nurses’ Association
What delivery method and item styles are established?
DNC uses computer-based testing with multiple-choice items organized around nursing practice. Applications are accepted year-round. Consult C-NET's current candidate materials for testing arrangements. The four-option questions in this guide are independent learning drills, not official examination items or a prediction of passing.
DNC: Dermatology Nurse Certified — C-NET · DNC Certification — Dermatology Nurses’ Association · Computer Based Testing Handbook–Application — DNCB
How are the four nursing objectives weighted?
The official objectives allocate 30% to assessment and monitoring, 30% to medical, surgical and phototherapeutic interventions, 29% to education, health promotion and psychosociocultural needs, and 11% to collaborative care coordination. This guide uses concise domain labels for those objectives. Its 60 concepts are allocated 18, 18, 17 and 7 respectively; the questions and flashcards each use a 6, 6, 6 and 2 allocation.
DNC Certification — Dermatology Nurses’ Association · Frequently Asked Questions — Dermatology Nurses’ Association
How do practice areas and patient-problem categories relate to the objectives?
These are intersecting classifications of the same examination content. Practice areas are General Dermatology 55%, Surgical Dermatology 30% and Phototherapy 15%. Patient-problem categories include infections and tumors/malignancies at 15% each, dermatitis and papulosquamous disorders at 13% each, and several smaller categories. These percentages are not added to the four objective percentages. This selective guide samples those categories; the official page and linked Patient Problem List provide the complete scope.
DNC Certification — Dermatology Nurses’ Association · DNC Patient Problem List
Which blueprint date applies to this guide?
The official materials identify a 2023 examination update but do not establish an explicit blueprint effective date. Use the official examination outline and Patient Problem List for the full scope.
DNC Certification — Dermatology Nurses’ Association · Frequently Asked Questions — Dermatology Nurses’ Association · DNC Patient Problem List
Which administrative details require confirmation before scheduling?
Use C-NET's DNC page and current candidate instructions to confirm application requirements, fees, identification rules, testing arrangements and the scheduling deadline on your authorization. Applications are accepted year-round. Confirm your individual permit dates before booking travel or a testing appointment.
DNC: Dermatology Nurse Certified — C-NET · Computer Based Testing Handbook–Application — DNCB
Dermatology Nurse Certified (DNC) is the registered nurse credential awarded by the Dermatology Nursing Certification Board. The separate dermatology nurse practitioner credential, DCNP, has a different professional scope and is not covered here.
Outline used: DNC examination identity independently confirmed on the live official testing administrator’s webpage; the issuer’s currently hosted FAQ and linked patient-problem list were opened and read on 2026-10-11. The FAQ filename includes 2022 but its text does not state a blueprint effective date. The supplied prior-candidate evidence records a 2023 examination update and additional blueprint classifications from the DNC webpage; that webpage returned 403 during this repair, so those additional facts are preserved as prior evidence rather than claimed as newly read webpage content. Workbook label 'Dermatology Certified Nurse (DCN)' is mapped to the evidenced RN credential, Dermatology Nurse Certified (DNC); the assigned slug is preserved. No separate current DCN examination was established.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Assessment and Monitoring30%
1.Which changing lesion features raise concern for melanoma?
Melanoma assessment emphasizes change and irregularity rather than a single reassuring feature. The ABCDE cues are asymmetry, an irregular border, varied color, diameter and evolution. Evolution includes a lesion changing in size, shape or color, or developing symptoms such as bleeding. Melanoma can be smaller than six millimeters; diameter is not a rule-out threshold. A spot that differs from the person's other lesions also deserves attention. Document the patient's observations and arrange clinical evaluation rather than treating inspection alone as diagnostic.
Apply it
A patient reports that a four-millimeter brown spot has developed an uneven dark edge and occasionally bleeds. Record the change, symptoms and lesion location, then facilitate dermatologic evaluation rather than reassuring the patient because the spot is small or longstanding.
Common pitfall: Neither long duration nor small diameter establishes benignity. ABCDE features guide recognition; every feature need not be present before evaluation is warranted.
2.Which findings suggest basal or squamous cell carcinoma?
Basal cell carcinoma may appear as a shiny or pearly raised growth, a scar-like area, a scaly patch or a sore that repeatedly heals and returns. It can be brown or black on darker skin. Squamous cell carcinoma often presents as a rough scaly patch, firm dome-shaped or wart-like growth, or persistent bleeding sore. These appearances overlap, so morphology directs assessment rather than establishing histology. Record persistence, growth, recurrent bleeding and location, and facilitate examination and diagnostic biopsy when indicated. See AAD guidance on [basal cell carcinoma](https://www.aad.org/public/diseases/skin-cancer/basal-cell-carcinoma/) and [squamous cell carcinoma](https://www.aad.org/public/diseases/skin-cancer/squamous-cell-carcinoma/).
Apply it
A patient calls a recurrent crusted nasal sore a scratch, while another reports an enlarging scaly nodule on the hand. Both patterns warrant assessment rather than repeated empirical wound treatment without investigating the persistent lesion.
Common pitfall: Absence of dark pigment does not reassure against skin cancer. Basal and squamous cell carcinomas do not have to resemble a changing mole.
3.How does a wound's trajectory help identify infection?
Wound assessment depends on the direction of change as well as the current appearance. Increasing pain, spreading redness or discoloration, warmth, swelling, pus or fever can indicate infection. Mild local discomfort immediately after a procedure has a different meaning from pain that worsens after initial improvement. Compare findings with the postoperative baseline and instructions. Report concerning progression so that infection can be evaluated rather than adding unprescribed products to the wound.
Apply it
Three days after a biopsy, a patient describes increasing pain, expanding warmth and thick drainage after initially improving. Arrange prompt clinical review and communicate the worsening trajectory, rather than interpreting all postoperative redness as expected healing.
Common pitfall: A single reassuring feature, such as an intact dressing, does not exclude infection. Progressive symptoms carry more weight than the mere presence of a healing wound.
How to treat minor cuts · Skin biopsy: Dermatologist-recommended wound care
4.Which dressing-related findings suggest contact irritation or allergy?
An itchy eruption that follows the shape of an adhesive or appears after applying a wound product suggests contact irritation or allergy. Routine topical antibiotics can themselves provoke allergic reactions. Assess the distribution, itch, product timing and wound symptoms together. Expanding warmth, increasing pain, purulent drainage or systemic illness requires a different level of concern. Contact-pattern clues help identify a possible exposure, but they do not prove that infection is absent.
Apply it
A clean biopsy site is surrounded by an itchy rectangular rash matching the adhesive border, without worsening pain or drainage. Review dressing and ointment exposures and communicate the pattern so the care plan can use a tolerated covering.
Common pitfall: Calling every postoperative rash infection invites unnecessary treatment. Conversely, recognizing an adhesive pattern should not prevent evaluation of concurrent pain, pus or fever.
5.When does a blistering eruption require emergency assessment?
A painful spreading rash with blistering or peeling and involvement of the mouth, eyes or genitals raises concern for Stevens-Johnson syndrome. A recent medication exposure and preceding flu-like illness strengthen concern. This is a potentially life-threatening reaction requiring immediate hospital assessment. The decisive distinction from a limited itchy eruption is the combination of skin pain, epidermal injury, mucosal disease and systemic illness. Collect medication timing without delaying emergency escalation.
Apply it
A patient who recently began a medicine reports fever, painful skin, mouth sores and new blisters. Activate emergency assessment and convey the medication timeline, mucosal involvement and progression rather than booking a routine rash visit.
Common pitfall: Reassuring the patient because the eruption began as small spots ignores its progression. Mucosal injury and painful blistering change the urgency substantially.
6.What mechanism distinguishes bullous pemphigoid from a contagious blistering infection?
Bullous pemphigoid is an autoimmune disorder in which the immune system attacks structures that help attach skin layers, producing separation and blisters. It often causes substantial itch and commonly affects older adults. The condition itself is not contagious, although open or ruptured blisters can become infected. Assessment therefore separates the underlying blistering process from complications: document new blister formation, symptoms and any increasing warmth, pain, pus or systemic illness.
Apply it
An older adult with diagnosed bullous pemphigoid worries about infecting a spouse. Explain the autoimmune basis while assessing a newly painful, draining blister for secondary infection and communicating the change to the treating team.
Common pitfall: Noncontagious does not mean complication-free. The autoimmune cause explains blister formation but does not protect damaged skin from a separate bacterial infection.
7.Which joint symptoms matter in a patient with psoriasis?
Psoriasis assessment extends beyond visible plaques because some patients develop psoriatic arthritis. Joint pain, swelling and stiffness, especially morning stiffness, deserve attention even when skin disease appears limited. Nail changes can also accompany psoriasis and should be documented alongside musculoskeletal symptoms. The nursing decision is to recognize a possible associated inflammatory joint disorder and facilitate assessment. Skin improvement alone does not establish that joint disease is absent or adequately controlled.
Apply it
A patient pleased with improving plaques mentions swollen fingers and prolonged stiffness on waking. Document the joint pattern and arrange clinician assessment rather than focusing the visit solely on the remaining body surface affected.
Common pitfall: Assuming joint pain is unrelated aging can miss associated disease. Limited skin involvement does not make persistent inflammatory joint symptoms unimportant or safely dismissible.
8.Why should suspected fungal nail disease be confirmed rather than inferred from appearance?
Nail dystrophy describes an abnormal appearance rather than a specific cause. Psoriasis can produce pitting, separation and changes that overlap with fungal disease; trauma can also alter nails. When fungal infection is suspected, a clipping or material from beneath the nail can help establish the cause before treatment, especially before a prolonged systemic course. Connect the nail findings with skin disease, symptoms and the diagnostic plan. Ensure the sample result reaches the treatment decision rather than assuming collection itself completes the assessment.
Apply it
A patient with psoriasis and a thick toenail requests an oral antifungal. Explain that similar nail changes have different causes and support the requested sampling before committing to treatment.
Common pitfall: Thickness does not confirm fungus, and psoriasis does not exclude coexisting infection. A photograph documents appearance but does not replace requested diagnostic testing.
Psoriasis: Signs and symptoms · Nail fungus: Diagnosis and treatment
9.How do hair-loss mechanisms change assessment and expectations?
Alopecia has several mechanisms. Alopecia areata involves immune attack on hair follicles, and regrowth may occur. Increased shedding appearing a few months after illness, childbirth or another major stressor has a different history. Scarring alopecia destroys follicles; a destroyed follicle cannot regrow hair, making early recognition important. Ask about timing, distribution, scalp symptoms, recent illness, medicines and hair practices. Distinguish hair shedding from progressive loss accompanied by scalp inflammation rather than promising that every form is temporary. See [AAD guidance on causes of hair loss](https://www.aad.org/public/diseases/hair-loss/causes/18-causes/).
Apply it
One patient reports increased shedding months after illness; another reports progressive loss with a symptomatic scalp. Document these different histories and facilitate assessment instead of assigning both patients the same explanation or supplement.
Common pitfall: Hair loss is a finding, not a single diagnosis. Waiting for spontaneous regrowth in every patient can miss disease that permanently destroys follicles.
10.How should nail appearance be interpreted during antifungal treatment?
Successful treatment does not instantly restore the appearance of an already damaged nail. A healthier nail must grow out, so visible normalization can lag behind control of fungal infection. Assess the treatment course, adherence, symptoms and emerging nail growth rather than declaring failure from the persistent appearance of the old nail plate. Continued or worsening abnormalities still merit review, but expectations must account for the slow replacement of affected nail.
Apply it
A patient has completed prescribed treatment but remains worried about the distal discolored toenail. Explain the growth-related delay and review the clinician's follow-up plan instead of recommending an immediate additional course solely from the old nail's appearance.
Common pitfall: Persistent discoloration is not automatic proof of active infection. Repeated treatment without reassessment can confuse slow nail growth with a failed treatment course.
11.Which delayed symptoms should be assessed before another UVB session?
Phototherapy can cause redness, burning, itching or blistering, and the important reaction may develop after the patient leaves the unit. Before another session, ask how the skin felt later that day and afterward, including soreness and the duration of redness. A comfortable appearance at arrival does not reconstruct the previous reaction. Report significant reactions and use the unit's prescribed assessment process before further exposure; do not independently invent a dose adjustment.
Apply it
A patient says the last UVB treatment felt fine in the booth but caused painful redness that evening. Document the delayed reaction and obtain review before proceeding with the planned exposure for today's appointment.
Common pitfall: Checking only for immediate booth discomfort misses delayed injury. The next treatment decision needs the interval history, not just a brief inspection on arrival.
Psoriasis treatment: Phototherapy · Narrowband UVB (TL-01) phototherapy
12.Why do medication changes matter during phototherapy?
Some medicines increase sensitivity to ultraviolet radiation and can alter the safety of a previously tolerated phototherapy exposure. Medication review therefore continues throughout treatment rather than ending at the first appointment. Ask about newly started, stopped or changed prescribed medicines and other products. Identify the medicine and notify the phototherapy team before treatment when relevant. Prior tolerance of the same machine setting cannot guarantee safety after the patient's photosensitivity has changed.
Apply it
Before UVB, a patient mentions starting an antibiotic yesterday but does not know its name. Obtain the medication details and have the phototherapy team review them before exposure rather than assuming the previous session proves today's safety.
Common pitfall: Medication reconciliation is not a one-time intake task. A new medicine can change risk even when the skin condition and scheduled exposure appear unchanged.
Narrowband UVB (TL-01) phototherapy · Psoriasis treatment: Phototherapy
13.How does exposure timing help assess suspected contact dermatitis?
Allergic contact dermatitis can be delayed, so the relevant exposure may precede the visible rash by more than an immediate reaction would suggest. Ask about work materials, personal products, adhesives and where each touches the skin. A distribution that matches exposure can guide investigation. Patch testing evaluates delayed contact allergy through scheduled readings. Exposure history and test results must be interpreted together because identifying sensitization is useful only when its clinical relevance is considered.
Apply it
A patient develops recurrent eyelid dermatitis after changing cosmetic products but reports no immediate stinging. Record the delayed timing and all products used near the area, and explain why patch testing may still be informative.
Common pitfall: Absence of an immediate reaction does not exclude delayed allergy. Limiting the history to products applied just before the rash can miss relevant exposures.
14.Which findings distinguish persistent scabies itch from possible ongoing infestation?
Scabies itch reflects hypersensitivity to mites and their products and may persist for several weeks after successful treatment. Early itch alone does not establish failure. CDC advises reassessment when itching persists more than 2–4 weeks after treatment, new burrows appear or new pimple-like lesions develop. These findings warrant evaluation for ongoing infestation, reinfestation or another cause rather than automatically proving treatment failure. Review application technique and contact treatment. Skin sores or suspected secondary infection require prompt contact with a healthcare professional.
Apply it
One week after treatment, a patient has improving itch without new lesions and confirms correct application and simultaneous household treatment. Explain residual hypersensitivity and give the specific 2–4-week and new-lesion reassessment criteria.
Common pitfall: Neither early itch nor a later warning sign alone proves resistance. Repeated scabicide use without evaluation can add irritation and obscure the explanation.
15.Why can vitiligo assessment extend beyond skin color?
Vitiligo involves loss of skin pigment and may be associated with other autoimmune conditions, including thyroid disease. Assessment includes the pattern and progression of pigment loss, medical history, symptoms and psychosocial effects. The clinician may use the history and examination to decide whether additional testing is appropriate. The key distinction is association rather than certainty: vitiligo does not mean every patient has another autoimmune disease or needs an identical laboratory panel.
Apply it
A patient seeking treatment for new depigmented patches also reports a history of thyroid disease. Document both concerns for the dermatologist rather than treating the pigment change as an isolated cosmetic issue without relevant medical context.
Common pitfall: An autoimmune association is not a universal diagnosis. Avoid telling every patient that vitiligo proves thyroid disease or that the same tests are mandatory.
16.How can psoriasis look different across skin tones?
Psoriasis does not produce the same visible color in every skin tone. Plaques may appear red or pink on lighter skin and more violet, dark brown or gray on darker skin, with scale that also varies in appearance. Assess texture, scale, thickness, distribution and symptoms rather than relying on redness alone. Changes in pigmentation may persist after inflammation improves, so residual color must be considered alongside other signs of active disease.
Apply it
A patient with dark skin describes thick, itchy plaques that look violet rather than bright red. Document the scale, elevation and symptoms without dismissing psoriasis because the color differs from a familiar textbook photograph.
Common pitfall: Using bright redness as the required sign of inflammation can underestimate disease. Color is one observation, and persistent pigment change does not necessarily indicate active plaques.
Psoriasis: Signs and symptoms · Can you get psoriasis if you have skin of color?
17.How can a rosacea diary identify meaningful triggers?
Rosacea triggers vary among individuals, so assessment benefits from linking flares with repeated exposures rather than imposing a universal avoidance list. A diary can record symptoms alongside heat, sunlight, foods, drinks, exercise, stress and skin products. Look for reproducible associations and discuss practical adjustments. A single coincidence does not prove causation. The useful decision is which personal exposure can be modified while preserving nutrition, activity and a manageable daily routine.
Apply it
A patient blames all spicy food for rosacea but notices flares mainly after hot outdoor exercise. Ask the patient to record timing, temperature, activity and symptoms to identify a more specific and usable pattern.
Common pitfall: Long universal restriction lists can burden patients without identifying their actual triggers. Repeated personal patterns are more informative than assuming every commonly reported trigger applies.
18.Which bleeding history changes the urgency of postoperative assessment?
Post-biopsy bleeding assessment should establish whether direct pressure has been applied correctly and whether bleeding stops. Ask about duration, repeated saturation and symptoms suggesting substantial blood loss. Continuous firm pressure is the initial measure described in biopsy guidance, but persistent bleeding despite that measure requires contact with the treating service. Severe or uncontrolled bleeding or faintness warrants urgent escalation. Distinguish minor oozing from ongoing loss rather than relying on the patient's word bleeding alone.
Apply it
A patient repeatedly lifts the dressing to inspect a biopsy site and reports continued oozing. Clarify the amount and symptoms, coach uninterrupted firm pressure, and explain when persistence requires immediate contact with the treating team.
Common pitfall: Repeatedly checking the site interrupts compression and can disturb clot formation. Conversely, continued significant bleeding should not be managed indefinitely with repeated home measures.
Medical, Surgical and Phototherapeutic Interventions30%
19.Why is a clean biopsy wound kept moist and covered?
Dermatologist-recommended biopsy care commonly combines gentle cleansing, plain petroleum jelly and a clean covering. Moist wound care prevents excessive drying and supports healing of the surface. Wash hands before care, clean as directed and replace the covering according to the procedure instructions. This general principle does not override a special repair or dressing plan. The decision is to preserve a clean, protected healing environment rather than deliberately creating a dry crust.
Apply it
A patient asks whether to leave a routine biopsy wound uncovered until a hard scab forms. Reinforce the prescribed gentle cleansing, petroleum jelly and covering plan, while checking whether any procedure-specific instructions modify that routine.
Common pitfall: Drying a wound is not automatically better healing. Scrubbing or using harsh products can injure the healing surface instead of making the wound cleaner.
20.Why are routine topical antibiotics usually unnecessary for a clean biopsy wound?
For routine clean biopsy wound care, plain petroleum jelly can maintain moisture without the allergic contact dermatitis risk associated with topical antibiotic ointments. An itchy reaction to an antibiotic product can complicate healing and resemble infection. This does not mean prescribed treatment for an established infection should be stopped. The nursing decision is to follow the specific wound plan and avoid adding an antibiotic merely because the skin has been opened.
Apply it
A patient with an uncomplicated biopsy wants to add an over-the-counter antibiotic ointment to the prescribed petroleum jelly. Explain the allergy risk and reinforce the existing plan rather than assuming an extra antimicrobial improves every wound.
Common pitfall: More products do not necessarily provide more protection. The recommendation for routine clean wounds does not replace clinician-directed treatment when infection is actually present.
21.How should initial biopsy-site bleeding be controlled?
For bleeding from a biopsy site, apply firm direct pressure with clean gauze and maintain it continuously for twenty minutes, as described in AAD biopsy guidance. Avoid repeatedly lifting the gauze to inspect the wound because this interrupts the pressure needed for clot formation. If bleeding continues, contact the treating clinician for further instructions. Significant uncontrolled bleeding or concerning systemic symptoms requires urgent assessment rather than prolonged attempts to manage the situation alone.
Apply it
A patient reports mild biopsy-site bleeding after repeatedly dabbing it with tissues. Coach firm uninterrupted pressure using clean gauze for the recommended interval, then explain the escalation plan if bleeding does not stop or becomes substantial.
Common pitfall: Dabbing removes blood without providing sustained compression. Do not advise patients to stop prescribed anticoagulants on their own as a substitute for proper bleeding management.
6 skin biopsy wound care tips from dermatologists · Pre & Post Mohs Surgery Information — SLUCare
22.How are therapeutic topical corticosteroids administered and monitored safely?
Topical corticosteroids suppress inflammation in disorders such as eczema and psoriasis. Match the prescribed potency, site, amount, frequency and duration; one preparation is not automatically suitable for every body area. Eyelids, face, groin and folds are more vulnerable to adverse effects. An adult fingertip unit extends from the fingertip to the first crease and covers approximately two adult hand-sized areas. Prolonged potent treatment can cause thinning, fragility, bruising or striae. Assess both response and skin changes. See [British Association of Dermatologists guidance](https://www.bad.org.uk/pils/topical-corticosteroids).
Apply it
A patient transfers a potent body treatment to eyelid eczema. Explain the site-specific risk and reconcile the correct preparation before further eyelid application; demonstrate the prescribed amount.
Common pitfall: Avoid both unsupervised prolonged use and arbitrary underapplication. Too little treatment can leave inflammation uncontrolled, while excessive potency or duration increases harm.
23.How does Mohs surgery use microscopic margin assessment?
Mohs surgery removes skin cancer in stages while examining the surgical margins microscopically. Removed tissue is mapped so that any remaining cancer can be related to a specific location. Additional tissue is taken from areas where cancer remains, and the process continues until the margins are clear. This combines tissue conservation with systematic margin assessment. Local anesthesia and waiting between stages are usual parts of the process. After clearance defines the final defect, the surgeon selects repair or healing options appropriate to the wound and location.
Apply it
A patient asks why another small layer is needed and why closure has not begun. Explain that microscopic examination found remaining cancer in a mapped area; definitive repair follows the stages needed to achieve clearance.
Common pitfall: A second stage does not necessarily mean the procedure failed. Promising a specific repair before the final defect is known can also mislead patients.
24.What administration and monitoring decisions accompany systemic prednisolone for bullous pemphigoid?
Prednisolone suppresses immune activity and can rapidly control new blister formation. A commonly prescribed regimen is a single morning dose after food, although the individual prescription governs administration. Monitor blister activity, blood pressure, blood glucose, infection symptoms, and longer-term bone and ocular risks. Patients must not independently stop or reduce ongoing systemic prednisolone when their skin improves. Sufficient exposure can suppress endogenous corticosteroid production; abrupt withdrawal can then leave inadequate corticosteroid activity and cause adrenal insufficiency. Dose reduction must follow the prescribed individualized plan. This does not mean that every short course requires tapering.
Apply it
A patient whose blisters have improved after several weeks of prednisolone plans to stop tomorrow. Explain that skin improvement does not establish recovery of endogenous corticosteroid production, and reinforce the prescribed withdrawal plan. Separately, marked thirst and frequent urination warrant assessment for hyperglycemia. Fever, cough, severe abdominal pain, black stools, visual changes or significant mood changes require prompt reporting.
Common pitfall: Monitoring only blister counts misses systemic toxicity and withdrawal risk. Do not give a universal taper schedule: the prescriber individualizes reduction according to treatment exposure and disease control. Confirm understanding by asking the patient to describe the current dose, planned changes and whom to contact before changing treatment.
25.What does patch testing investigate?
Patch testing investigates delayed allergic contact dermatitis by placing small amounts of selected substances on the skin and checking for a reaction over time. It differs from testing designed around immediate allergic responses. The clinician interprets the reaction and determines whether the substance is relevant to the patient's exposures and rash. Explain that the result can guide ingredient avoidance, but the test does not establish every possible cause of dermatitis.
Apply it
A patient with recurrent hand dermatitis expects a same-day answer about workplace products. Explain that patch testing examines delayed reactions through scheduled readings and that the exposure history helps interpret any positive findings.
Common pitfall: Patch testing is not a universal test for all rashes or all allergies. A positive result still needs interpretation in relation to actual exposure.
26.Why must patch-test sites and later readings be protected?
Patch testing depends on controlled skin contact and observation of delayed reactions. Patients need the testing service's instructions about keeping patches and marked areas dry, avoiding activities that loosen them and returning for later readings. A reaction may become apparent after the initial removal, so completing only the first visit can leave the evaluation incomplete. The intervention is to preserve interpretable testing conditions and the full reading schedule rather than seeking an immediate answer.
Apply it
A patient plans strenuous exercise while patches are attached and intends to skip the final reading if the skin looks clear. Review the site's activity restrictions and explain why delayed readings remain necessary even without an early reaction.
Common pitfall: Early absence of a reaction does not complete a delayed-allergy evaluation. Loose patches, lost markings or missed readings can reduce the usefulness of testing.
27.What is the standard eye protection during narrowband UVB, and when is an exception appropriate?
Approved UV-protective goggles are standard during narrowband UVB. Patients must not independently remove them or substitute closed eyes. A specific exception is clinician-directed treatment of eyelid dermatoses using complete eyelid closure after assessing the patient's ability to adhere reliably; negligible UVB passes through completely closed eyelids. Confirm and document the prescribed approach before exposure. This exception does not apply to PUVA, which requires its own ocular precautions. See [Leeds narrowband-UVB guidance](https://www.leedsth.nhs.uk/patients/resources/narrow-band-uvb-treatment/) and the [BAD/BPG narrowband-UVB guideline](https://onlinelibrary.wiley.com/doi/10.1111/bjd.21669).
Apply it
A patient independently removes prescribed goggles because they are uncomfortable and offers to close the eyes. Pause the setup and arrange suitable protection; an eyelid-treatment exception requires prior clinical assessment and direction.
Common pitfall: Neither a blanket prohibition on clinician-directed eyelid treatment nor permission for patients to improvise protection accurately reflects narrowband-UVB practice. Do not transfer the exception to PUVA.
Narrowband UVB (TL-01) phototherapy · DailyMed - METHOXSALEN capsule, liquid filled
28.Why should skin coverage remain consistent during a UVB course?
Phototherapy exposure is planned around the skin being treated and the unit's shielding instructions. Changing clothing or exposing an area that was previously covered can give relatively unexposed skin an unexpectedly large exposure. Follow the agreed coverage and protection plan consistently, including any prescribed shielding. Ask about changes before the session. The relevant comparison is each skin area's prior exposure, not simply the patient's overall history of receiving UVB.
Apply it
After several sessions in underwear, a patient wants to uncover previously shielded skin because nearby plaques are improving. Explain the exposure difference and obtain team instructions before altering coverage for the next treatment.
Common pitfall: Previously treated skin and previously covered skin do not share the same exposure history. A patient-level record alone does not justify changing shielding without review.
29.How should a significant UVB reaction affect treatment delivery?
Painful redness, blistering or other significant reactions after UVB require assessment before another exposure. Document the timing, severity and duration, and communicate with the phototherapy clinician under the unit's protocol. The subsequent plan may need modification, but a universal adjustment cannot be inferred from a short symptom description. The immediate nursing decision is to prevent unreviewed additional exposure while ensuring that the reaction and any changed medicines or sunlight exposure are considered.
Apply it
A patient arrives for scheduled UVB with tender skin after a weekend sunburn. Do not automatically deliver the planned session; document the additional exposure and obtain the phototherapy team's assessment before further irradiation.
Common pitfall: A scheduled appointment is not authorization to ignore an interval burn. Independently choosing a smaller exposure also bypasses the assessment needed to understand the reaction.
Psoriasis treatment: Phototherapy · Narrowband UVB (TL-01) phototherapy
30.What distinguishes PUVA from narrowband UVB?
PUVA combines a psoralen photosensitizing medicine with ultraviolet A exposure. Narrowband UVB uses a different ultraviolet band and does not require that psoralen combination. The medicine-light pairing explains why PUVA preparation and post-treatment precautions cannot simply be copied from UVB instructions. Confirm the prescribed modality and whether psoralen is oral or topical. The nursing task is to implement the correct protocol rather than treating all phototherapy as interchangeable light treatment.
Apply it
A patient changing from UVB to PUVA assumes the same preparation applies. Explain the addition of psoralen and UVA, then review the new modality-specific instructions instead of reusing the previous UVB handout without discussion.
Common pitfall: UVA and UVB are not interchangeable labels. PUVA includes a photosensitizer, and oral versus topical psoralen also changes which precautions are relevant.
31.Why does oral methoxsalen require eye protection beyond the PUVA booth?
With oral methoxsalen, the drug enters the lens. UVA exposure while it is present can cause irreversible photochemical binding to lens proteins and DNA; sufficient binding is associated with cataract formation. The product labeling specifies UVA-absorbing wraparound sunglasses for 24 hours after ingestion when exposed to direct or indirect sunlight, including through window glass. Side coverage matters because stray UVA can enter around ordinary frames. UVA-blocking goggles are required during treatment. Review the service's full regimen-specific instructions; oral precautions must not automatically be assigned to every topical-psoralen regimen.
Apply it
A patient taking oral methoxsalen plans to ride home beside a sunny window wearing ordinary fashion sunglasses. Check that the eyewear provides UVA absorption and wraparound protection, and teach the labeled 24-hour precaution.
Common pitfall: Leaving the booth, sitting indoors beside a window or choosing dark lenses does not establish adequate UVA protection. Lens darkness alone does not verify the required filtering.
DailyMed - METHOXSALEN capsule, liquid filled · Psoriasis treatment: Phototherapy
32.Why is benzoyl peroxide paired with topical acne antibiotics?
Acne treatment uses combinations that address different processes while reducing avoidable antibiotic resistance. Current AAD guidance recommends using topical antibiotics with benzoyl peroxide rather than as antibiotic monotherapy. Benzoyl peroxide contributes antibacterial activity and helps limit resistance selection. Confirm that the patient understands how the prescribed combination is used and can tolerate it. Do not substitute indefinite antibiotic use for reassessment or assume that adding more antibiotics improves long-term acne control.
Apply it
A patient uses topical clindamycin but stopped the prescribed benzoyl peroxide because it seemed redundant. Explain the resistance-related purpose of the combination and discuss tolerability with the treating team instead of endorsing antibiotic-only treatment.
Common pitfall: Two products are not necessarily duplicative. Removing benzoyl peroxide can undermine a deliberate antibiotic-stewardship strategy even when the remaining antibiotic initially appears effective.
33.How do topical retinoids support acne maintenance?
Topical retinoids help prevent clogged pores and formation of new acne lesions, so they can remain useful after an inflammatory flare improves. Maintenance treatment addresses the continuing tendency to develop lesions rather than treating only visible spots. Explain the prescribed application plan and address irritation so adherence is realistic. Maintenance does not imply that every medicine in the initial regimen should continue indefinitely, especially antibiotics whose ongoing need should be reassessed.
Apply it
After acne improves, a patient wants to stop every topical product and restart an antibiotic whenever spots return. Explain the preventive role of the prescribed retinoid and clarify which parts of the plan are intended for maintenance.
Common pitfall: Clearer skin does not always mean the tendency to form acne has ended. Maintenance treatment and prolonged antibiotic exposure have different purposes and safety considerations.
34.Why can a corticosteroid worsen suspected ringworm?
Ringworm is a fungal infection, and a corticosteroid does not eliminate the organism. An unsupervised steroid cream can suppress inflammation, change the rash's appearance and allow the infection to worsen or spread. CDC guidance advises against steroid creams for ringworm or a rash that may be ringworm. The clinical decision is to establish the likely cause and use appropriate antifungal treatment rather than interpreting temporary reduction in redness as evidence of cure.
Apply it
A patient reports that an expanding circular rash briefly looked calmer with an over-the-counter steroid but then spread. Explain why reduced inflammation does not prove fungal clearance and arrange assessment for appropriate treatment.
Common pitfall: Symptom suppression can disguise progression. A cream that reduces itch or redness is not necessarily treating the underlying organism responsible for the eruption.
35.Why does the site of ringworm change treatment selection?
Ringworm treatment depends on the infected site. Many skin infections can be treated with topical antifungals, whereas scalp ringworm generally requires prescription medicine taken by mouth; creams alone do not adequately treat infection within affected hair. Nail disease also requires its own assessment and treatment plan. Identify scalp involvement and hair changes rather than extending a skin-rash regimen to every site. Site-specific treatment is a mechanism-based distinction, not simply a preference for stronger therapy.
Apply it
A parent asks whether an antifungal cream used for a child's body rash will also cure a scaly scalp patch with hair loss. Explain the need for medical assessment because scalp infection generally requires oral prescription treatment.
Common pitfall: Treatments for superficial body skin do not automatically reach infected hair. Do not recommend a longer cream course as a substitute for assessing scalp disease.
36.How should prescribed scabies treatment be implemented safely?
For an adult prescribed permethrin 5% cream for classic scabies, CDC describes application over the body from the neck down, followed by washing it off after 8–14 hours. Another application about one week later may be necessary. Treat the instructed body area rather than only itchy spots. Infant and young-child instructions differ: the head and neck may also need treatment, and only an age-appropriate prescribed product should be used. In the United States, no nonprescription product is approved to treat human scabies. See [CDC clinical care guidance](https://www.cdc.gov/scabies/hcp/clinical-care/).
Apply it
An adult applies prescribed permethrin only to visible lesions. Use teach-back to correct whole-body application, the 8–14-hour contact time and any ordered repeat application, while coordinating contact treatment and textile measures.
Common pitfall: Do not transfer adult neck-down instructions to infants, substitute household insecticides or repeat treatment indefinitely for residual itch. Product, age and clinical presentation determine the actual regimen.
Education, Health Promotion and Psychosociocultural Care29%
37.How should bathing and immediate aftercare support atopic skin?
Atopic skin benefits from gentle cleansing that avoids excessive drying and irritation. Teach short baths or showers with warm rather than hot water, gentle handling and prompt application of moisturizer after bathing. The aim is to clean the skin while supporting its barrier and reducing water loss. Connect the advice to the patient's routine so it is achievable. More frequent scrubbing or hotter water does not correct the underlying barrier problem.
Apply it
A patient takes long hot showers to relieve itch but feels drier afterward. Help the patient plan shorter warm showers, gentle drying and immediate moisturizer placement where it will be used after bathing.
Common pitfall: Temporary comfort from hot water can be followed by more dryness. Aggressive cleansing can aggravate the same barrier dysfunction the patient is trying to relieve.
38.Why is regular moisturization useful between eczema flares?
Moisturizers help retain water and support the skin barrier, so their value extends beyond visibly inflamed patches. Regular use can reduce dryness and support comfort between flares. Product choice should account for tolerability, consistency and the patient's ability to use it regularly; creams or ointments may be more helpful for very dry skin than a thin lotion. Moisturization supports the plan but does not automatically replace prescribed treatment for active inflammation.
Apply it
A patient stops moisturizer whenever the rash fades and restarts only after severe dryness returns. Explain its continuing barrier role and agree on a practical daily routine alongside the clinician's separate instructions for flare treatment.
Common pitfall: Using moisturizer only as rescue care misses its preventive role. Conversely, persistent inflamed disease may still need prescribed therapy rather than progressively thicker moisturizer alone.
39.Which product labels help patients with sensitive atopic skin?
Fragrance-free products are preferable when fragrance worsens sensitive or atopic skin. Unscented is not equivalent: a product may contain ingredients that mask odor while still exposing the skin to fragrance-related substances. Teach patients to read the label rather than infer suitability from a neutral smell or natural-sounding branding. A product can still irritate an individual despite an appropriate label, so tolerability and the person's prior reactions remain part of selection.
Apply it
A patient buys an unscented moisturizer because it has no obvious smell but develops itching. Explain the label distinction and help identify a fragrance-free alternative while reviewing whether the product should be discontinued and the reaction assessed.
Common pitfall: Natural, botanical and unscented do not guarantee suitability for eczema. A label claim should guide selection without replacing attention to the patient's actual response.
40.How should sunscreen selection, renewal and other protection fit together?
Choose broad-spectrum, water-resistant sunscreen with SPF 30 or higher. Broad-spectrum protection addresses UVA and UVB; SPF alone does not describe the full protection profile. Apply adequately to exposed skin, including ears and neck, and reapply about every two hours outdoors and after swimming or sweating according to directions. Combine sunscreen with shade and protective clothing. For pigment-related concerns, a tinted product containing iron oxide can add visible-light protection; tint alone does not establish adequate sunscreen protection.
Apply it
An outdoor worker uses a high-SPF facial product once each morning. Build a plan covering exposed ears and neck, reapplication during the shift, protective clothing and shade; consider iron oxide when visible-light-related darkening is relevant.
Common pitfall: High SPF and water resistance do not make one application last all day. Makeup tint also does not replace broad-spectrum labeling, adequate application or renewal.
41.Which ulcer features should patients report instead of treating every lesion as an ordinary wound?
Pyoderma gangrenosum can begin as a small bump or blood blister that rapidly becomes a large painful ulcer. A blue-purple or darker border and onset after skin injury can be clues, particularly with inflammatory bowel disease or inflammatory arthritis. Infection, vascular ulcers and tumors can resemble it, so appearance alone does not establish the cause. Teach patients to report rapid enlargement, substantial pain and a nonhealing course, and to avoid picking or other unnecessary trauma. Protective dressings and immune-directed treatment may be needed after assessment. See [NHS pyoderma gangrenosum guidance](https://www.nhs.uk/conditions/pyoderma-gangrenosum/).
Apply it
A patient with inflammatory bowel disease describes a painful leg spot that rapidly ulcerated after a minor graze. Arrange clinical assessment and explain why repeated self-treatment as a simple infected cut may delay the correct diagnosis.
Common pitfall: Drainage does not establish that an ulcer is primarily infectious. Conversely, suspected inflammatory ulceration does not exclude secondary infection or other causes requiring evaluation.
42.How should recurrent fold lesions prompt teaching about hidradenitis suppurativa?
Hidradenitis suppurativa may cause deep painful nodules or abscesses that repeatedly return in the axillae, groin, buttocks or other folds. Repeated opening and healing can lead to scars and tunnels beneath the skin. Teach patients to describe recurrence in the same sites, drainage, pain and effects on movement or relationships rather than reporting each episode as an unrelated pimple. Early assessment can identify a continuing disease process and guide treatment before further scarring. See [AAD guidance on hidradenitis suppurativa symptoms](https://www.aad.org/public/diseases/a-z/hidradenitis-suppurativa-symptoms).
Apply it
A patient repeatedly seeks care for painful groin lumps and is embarrassed by drainage. Ask about previous episodes, scars and other affected folds, acknowledge the burden and facilitate a continuing dermatology plan.
Common pitfall: Treating every recurrence as an isolated boil can miss the pattern. Drainage and odor also deserve practical wound and psychosocial support rather than judgment.
43.Why are blood tests and interaction teaching essential with steroid-sparing bullous pemphigoid medicines?
Dapsone and azathioprine can reduce systemic steroid requirements but require specific safety monitoring. Dapsone can cause hemolysis and liver inflammation. Azathioprine can cause marrow suppression, liver toxicity and increased infection susceptibility; CBC with platelets is essential monitoring, alongside ordered liver tests. Azathioprine is converted to mercaptopurine. Allopurinol inhibits xanthine oxidase, reducing inactivation of azathioprine-derived mercaptopurine and increasing toxicity, including potentially life-threatening marrow suppression. Any intentional combination requires a specialist-directed substantial reduction in azathioprine dose and close monitoring. Patients must not adjust either medicine themselves.
Apply it
A patient taking azathioprine has missed laboratory appointments because the blisters are controlled and now has a gout prescription. Identify the gout medicine and urgently communicate any allopurinol prescription to the prescriber and pharmacist before coadministration. If both medicines are already being taken, arrange urgent clinical review. Explain that CBC with platelets can detect falling blood counts before skin appearance reveals a problem.
Common pitfall: Calling this merely an important interaction understates its mechanism and severity. Controlled blisters do not exclude marrow or liver toxicity. Reinforce attendance for laboratory monitoring and prompt reporting of persistent sore throat, prolonged fever, unusual bruising or bleeding. A patient should never attempt the substantial azathioprine dose reduction without specialist instructions.
44.Why should scabies contacts be treated at the same time?
Household members and close contacts may carry scabies before symptoms appear. Treating only the person who is itching can leave a source for reinfestation. CDC recommends simultaneous treatment of household members and close contacts according to clinical instructions. Explain the reason without assigning blame or assuming poor hygiene. The useful household plan identifies who needs treatment, when each person will complete it and how shared clothing and bedding will be managed.
Apply it
A patient finishes scabies treatment while an asymptomatic partner plans to wait for itching. Explain that symptoms can be delayed and help coordinate simultaneous contact treatment rather than relying on symptoms to identify every affected person.
Common pitfall: Absence of itch does not reliably exclude infestation in a close contact. Staggered treatment can undermine an otherwise correctly completed individual treatment course.
45.How should recently used textiles be handled during scabies treatment?
Environmental measures focus on clothing, towels and bedding used during the three days before scabies treatment. CDC recommends hot washing and hot drying, dry cleaning, or sealing items that cannot be cleaned in a closed plastic bag for several days to a week. This complements treatment of people. Explain a feasible method for each item rather than recommending indiscriminate disposal. Household insecticide sprays and fumigants are not recommended for scabies control.
Apply it
A family can hot-wash bedding but has a delicate garment that cannot be laundered. Review dry cleaning or temporary sealed storage for that item and coordinate these measures with the household's treatment day.
Common pitfall: Throwing away every possession is unnecessary, while cleaning without treating contacts is incomplete. Environmental measures and effective treatment address different parts of the transmission problem.
46.How can ringworm self-care support treatment rather than spread infection?
Ringworm care includes using the recommended antifungal for the instructed course and keeping affected skin clean and dry. Patients should avoid sharing personal items such as towels and should seek assessment when the site or course requires prescription treatment. Explain that symptom improvement may occur before the treatment instructions are complete. The educational goal is to connect treatment adherence and basic transmission precautions without substituting home remedies or steroid creams for appropriate antifungal care.
Apply it
A patient stops an antifungal when itch improves and shares a towel with a partner. Review completion of the instructed course, keeping the area dry and using separate personal items to support recovery and reduce spread.
Common pitfall: Early symptom relief is not a reason to improvise a shorter course. Adding a steroid cream may mask the infection rather than improve antifungal treatment.
47.How can rosacea teaching preserve activity while reducing flares?
Trigger management should adapt the patient's activities to identified patterns rather than automatically eliminating everything associated with rosacea. If heat is a trigger, cooler settings, cooling strategies or adjusted timing may make activity more tolerable. A diary helps select changes that actually relate to flares. Discuss realistic alternatives and monitor response. The aim is an individualized plan that reduces exposure to relevant triggers while retaining useful exercise, social participation and daily routines.
Apply it
A patient wants to abandon exercise because hot classes provoke flushing. Discuss cooler exercise conditions and timing, then use a symptom diary to evaluate whether those changes help before imposing a broad restriction on activity.
Common pitfall: Avoiding every possible trigger can create unnecessary limitations. A useful recommendation addresses the patient's demonstrated pattern and includes a practical alternative that can be sustained.
Triggers could be causing your rosacea flare-ups · How to prevent rosacea flare-ups
48.Why should patients with vitiligo reduce avoidable skin injury?
New vitiligo patches can develop in areas of skin injury, a phenomenon that makes trauma prevention relevant to self-care. Discuss avoiding unnecessary skin damage, including injury from tattoos or repeated friction when applicable. This does not mean all ordinary activity must stop or that every scratch will create a lesion. The decision is to reduce avoidable injury while preserving function and explaining the uncertainty of any individual response.
Apply it
A patient with vitiligo plans a tattoo over unaffected skin to distract attention from existing patches. Explain that tattoo-related injury may be followed by new depigmentation and encourage an informed discussion before proceeding.
Common pitfall: Do not promise that trauma will always cause a patch or never matter. The association supports informed prevention without making the patient afraid of all movement.
49.How should psychosocial distress from vitiligo be addressed?
Vitiligo can affect confidence, relationships and participation even when it does not cause pain. Ask how the condition affects the person's life and which goals matter, rather than assuming appearance concerns are trivial. Discuss available treatment, optional camouflage and support resources in line with patient preferences. Psychological support may be valuable when distress is significant. Respecting a choice to use or decline camouflage preserves autonomy while acknowledging the real burden of visible disease.
Apply it
A patient has stopped attending social events because of visible depigmentation. Explore the impact, offer information about treatment and support, and ask whether cosmetic camouflage is of interest instead of prescribing concealment as the expected solution.
Common pitfall: Calling vitiligo merely cosmetic can silence important distress. Conversely, assuming every patient wants camouflage can impose the clinician's appearance preferences on the patient's goals.
Vitiligo: How to make it less visible and prevent spreading · Vitiligo: Diagnosis and treatment
50.How should acne treatment expectations support adherence?
AAD patient guidance describes at least 6–8 weeks of treatment before fewer breakouts begin to appear; substantial improvement can take longer. Explain the purpose of each prescribed component and arrange review of response rather than encouraging product changes every few days. Troublesome irritation or other adverse effects warrant earlier contact, not forced continuation until a time target. Ask about cost, complexity and access. Maintenance may remain useful after visible lesions decrease.
Apply it
A patient changes acne products every few days because new lesions continue. Explain the 6–8-week initial expectation, agree on review timing and a plan for earlier contact about adverse effects, and address practical barriers to consistent use.
Common pitfall: A few days without improvement is not an adequate trial. The expected response time is also not a reason to ignore significant irritation, worsening symptoms or another diagnosis.
51.How does teach-back reveal whether instructions are usable?
Teach-back asks the patient to explain or demonstrate the plan in their own words so the clinician can assess the clarity of the teaching. It is not a memory test or a request to repeat technical wording. Use a nonjudgmental invitation, identify gaps, explain again in a different way and recheck. For dermatology, demonstration can reveal errors in application site, sequence or contact time that a simple question about understanding would miss.
Apply it
After explaining wound care, ask the patient to show how the site will be cleaned and covered at home. If the patient plans to scrub it with alcohol, reteach that step and check understanding again.
Common pitfall: Asking whether everything is understood often produces agreement without evidence. Teach-back evaluates the explanation's effectiveness and should not embarrass the patient for an unclear plan.
52.Why does psoriasis education include more than plaque appearance?
Psoriasis can involve nails and joints as well as the skin, so education should help patients recognize symptoms worth reporting. Explain that new joint swelling, pain or morning stiffness deserves assessment even when plaques improve. Discuss visible changes without implying that the person caused the condition through inadequate cleansing. Connecting education to symptoms the patient can observe supports earlier reporting and reduces the tendency to judge the entire disease by skin color or plaque size.
Apply it
A patient thinks nail pitting and morning finger stiffness are too minor to mention because the plaques are smaller. Explain why these findings belong in the follow-up discussion and help the patient describe their timing.
Common pitfall: A skin-only explanation can leave patients unaware of relevant associated symptoms. Improvement in visible plaques should not discourage reporting persistent joint or nail changes.
53.How does sun protection support vitiligo self-care?
Depigmented skin has reduced natural pigment protection and can burn easily. Sun protection helps prevent injury and can reduce the contrast created when surrounding pigmented skin tans. Teach sunscreen, shade and protective clothing as practical measures, and discourage deliberate tanning as a way to blend patches. This advice protects the skin but does not imply that sunlight avoidance alone treats the autoimmune process or guarantees repigmentation of established lesions.
Apply it
A patient plans to tan the surrounding skin to make vitiligo less noticeable. Explain that tanning can increase contrast and expose depigmented areas to burning, then discuss protection and optional camouflage consistent with the patient's goals.
Common pitfall: A tan can make the color difference more visible rather than conceal it. Sun protection and disease-directed treatment have related but distinct purposes.
Care Coordination11%
54.How should blood-thinner use be coordinated before Mohs surgery?
Preoperative medication reconciliation should identify prescribed anticoagulants and antiplatelet medicines, their indications and the clinicians managing them. Do not direct patients to stop a medically necessary blood thinner on their own. Interruption can create thrombotic risk, while continuation affects bleeding planning. Communicate with the surgical team and relevant prescriber so the patient receives one explicit individualized instruction. A universal stopping schedule is inappropriate because medication, indication and patient risk differ.
Apply it
A patient taking a prescribed anticoagulant asks whether to omit several doses before Mohs surgery. Confirm the medicine and indication, relay the question to the surgical team and prescriber, and ensure the resulting instruction is documented clearly.
Common pitfall: A generic handout about avoiding certain medicines should not trigger unsupervised interruption of a prescribed blood thinner. Conflicting instructions require resolution before the procedure.
55.How should phototherapy and outside prescribing be linked?
Patients may receive new medicines from clinicians who do not know they are undergoing phototherapy. Coordination connects those prescribing changes with the phototherapy team before the next exposure. Obtain the exact medicine, route and start date, communicate the change and document the treatment decision. Tell the patient how to report future changes. The goal is a reliable information pathway, rather than leaving the patient to decide independently whether a medicine is photosensitizing.
Apply it
An urgent-care clinician prescribes a new medicine between UVB appointments. Help the patient provide the name and start date to the phototherapy unit and confirm that the team has reviewed it before the next scheduled exposure.
Common pitfall: Telling patients to report only medicines they recognize as photosensitizing places an expert screening task on them. Reporting all changes permits the appropriate team to assess relevance.
56.What makes biopsy-result tracking a closed process?
Safe testing extends from ordering and specimen handling through result receipt, clinician review, patient communication and appropriate follow-up. A tracking system should identify the responsible clinician and detect results that have not arrived when expected. Receipt alone does not establish that a patient was informed or that an indicated action occurred. Apply this process to skin pathology and other dermatology tests, with documentation that shows how the result changed or confirmed the care plan.
Apply it
A biopsy is documented, but no pathology result appears in the expected interval. Use the tracking process to locate the specimen and result, identify the responsible reviewer and ensure the patient receives the completed interpretation and plan.
Common pitfall: No news is not evidence of a normal result. A missing report, unread report and uncommunicated report are different failures that each require follow-through.
57.Why does an abnormal result need an identified action owner?
An abnormal result creates a sequence of decisions and tasks, such as clinician interpretation, patient discussion, referral or treatment scheduling. Assigning a responsible person and a follow-up method prevents the result from becoming an acknowledged but unfinished message. Document what action is required, who will perform it and how completion will be verified. This extends result tracking beyond delivery of information to the clinical response that the information requires.
Apply it
A pathology report has been reviewed and a referral requested, but no appointment is recorded. Identify who is responsible for confirming the referral outcome and contact the patient to resolve barriers rather than marking the result complete.
Common pitfall: Sending a referral does not prove care occurred. Closing a result solely because a message was sent can leave a clinically important next step unfinished.
58.How can a handoff preserve a patient's ability to follow the plan?
A transition between clinicians or services should carry the current plan, relevant treatment changes and clear instructions about follow-up. Check the patient's understanding with teach-back rather than assuming that receipt of paperwork ensures comprehension. If the patient cannot describe the next action, clarify it and communicate unresolved gaps to the receiving team. The coordination task is to make the plan continuous across settings, including who will answer questions when problems arise.
Apply it
After a dermatology visit, a patient cannot explain whether to continue an old product while beginning a new one. Resolve the conflicting instructions with the prescribing team and confirm the patient can describe the final plan before departure.
Common pitfall: Forwarding two inconsistent medication lists preserves confusion rather than continuity. The patient should not have to infer which clinician's instruction supersedes the other.
59.How should barriers to simultaneous scabies treatment be coordinated?
Effective household scabies management requires more than telling contacts to seek treatment. Identify barriers such as separate clinicians, medication access, shared caregiving and inability to clean textiles on the same day. Help the household arrange a coherent treatment and environmental plan while respecting each person's clinical needs. Coordination reduces the gap between technically correct instructions and achievable simultaneous action. Avoid assuming that an untreated contact is deliberately disregarding advice.
Apply it
One household member cannot obtain prescribed treatment until later in the week. Alert the treating team and help align access and instructions for the household rather than allowing staggered treatment to proceed without considering reinfestation.
Common pitfall: Repeatedly treating one person without addressing access barriers in contacts may perpetuate the cycle. Coordination should solve the practical obstacle rather than assign blame.
60.Which information should accompany an emergency blistering-rash handoff?
When a painful blistering rash with mucosal involvement raises concern for Stevens-Johnson syndrome, emergency transfer should include the eruption's onset and progression, affected mucosal sites, systemic symptoms and medication history. Identify recently started medicines and known allergies when available. Communicate the concern directly to the receiving service while arranging immediate assessment. Gathering a perfect chronology must not postpone escalation; the handoff should make the severity and possible drug association clear.
Apply it
A patient with mouth erosions, fever and spreading painful blisters is being sent for emergency assessment. Provide the receiving team with the new medication's name, start date and rash progression while ensuring transfer proceeds without delay.
Common pitfall: A routine referral message can understate an emergency. Conversely, spending excessive time completing every historical detail can delay the hospital assessment the presentation requires.
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Distinguish evolving melanoma, basal and squamous cell carcinoma warning signs, serious blistering drug reactions and progressive wound infection.
- Use diagnostic nail sampling, hair-loss mechanisms, delayed patch-test readings and interval phototherapy history to interpret findings.
- Connect moist wound care, sustained pressure and staged Mohs margin assessment with their specific purposes; recognize atypical nonhealing ulcers.
- Separate narrowband UVB from PUVA, including clinician-directed eyelid protocols and oral methoxsalen's labeled eye precautions.
- Practise medication administration and monitoring for topical corticosteroids, systemic prednisolone, steroid-sparing medicines, acne therapy and scabies treatment.
- Give usable teaching for eczema, sun protection, scabies, acne, rosacea, hidradenitis suppurativa and pigmentary disease while addressing psychosocial goals.
- Close the loop on pathology, referrals, conflicting medication instructions and barriers to coordinated treatment.
- Expand revision beyond these selected concepts using the complete official examination outline and Patient Problem List.
A practical preparation plan
1. Map revision to both nursing objectives and clinical areas
Use the 30%/30%/29%/11% objective weights to distribute study time. Cross-check the same topics against general dermatology, surgery and phototherapy, then mark gaps against the complete official Patient Problem List.
2. Build discriminating comparisons
Compare changing small lesions with stable lesions, delayed contact reactions with infection, residual scabies itch with new burrows, and slow nail replacement with confirmed treatment failure. Add comparisons of scarring versus potentially reversible hair loss and ordinary wounds versus rapidly progressive painful ulcers.
3. Rehearse procedure and medication decisions
Explain why a wound is kept moist, why pressure must be uninterrupted and why Mohs proceeds in stages. Demonstrate site-specific topical treatment and scabies application. Connect systemic medicines with the symptoms, laboratory tests and interactions that affect safety.
4. Practise teaching aloud
Give a brief home-care explanation, then use teach-back to check application steps, reapplication timing or household treatment coordination. Include realistic barriers, patient preferences and concrete reassessment thresholds.
5. Use the drills to expose reasoning gaps
Answer the 20 questions before reading explanations. For every error, identify the decisive cue and explain why each competing action is less suitable. Revisit related flashcards and the supporting clinical source; do not treat the score as a pass prediction.
6. Finish with scope and candidate-material checks
Review conditions and procedures absent from this selective guide through the official outline and recommended references. Before applying, confirm eligibility, delivery and scheduling instructions with C-NET's current DNC materials.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- DNC Certification — Dermatology Nurses’ Association
- Mission and Philosophy
- DNC Patient Problem List
- DNC Certification Application and Exam Brochure — 2023
- DNC Computer Based Testing Handbook — historical 2020 application
- Melanoma: Signs and symptoms
- Skin biopsy: Dermatologist-recommended wound care
- 6 skin biopsy wound care tips from dermatologists
- How to treat minor cuts
- Stevens-Johnson syndrome
- Psoriasis: Signs and symptoms
- Nail fungus: Diagnosis and treatment
- Psoriasis treatment: Phototherapy
- Narrowband UVB (TL-01) phototherapy
- The Mohs Surgery Procedure
- Patch testing can find what’s causing your rash
- Atopic dermatitis skin care
- How to apply sunscreen
- Preventing Scabies
- Treatment of Scabies
- Triggers could be causing your rosacea flare-ups
- Acne clinical guideline
- Acne: Diagnosis and treatment
- Vitiligo: How to make it less visible and prevent spreading
- Vitiligo: Diagnosis and treatment
- Pre & Post Mohs Surgery Information — SLUCare
- Improving Your Laboratory Testing Process
- Bullous pemphigoid
- Treatment of Ringworm
- Use the Teach-Back Method: Tool 5
- Frequently Asked Questions — Dermatology Nurses’ Association
- DNC: Dermatology Nurse Certified — C-NET
- Computer Based Testing Handbook–Application — DNCB
- Bullous Pemphigoid
- Can you get psoriasis if you have skin of color?
- DailyMed - METHOXSALEN capsule, liquid filled
- How to prevent rosacea flare-ups
- Basal cell carcinoma: From symptoms to treatments
- Squamous cell carcinoma: From symptoms to treatments
- Hair loss: Who gets and causes
- Topical corticosteroids
- Pyoderma gangrenosum - NHS
- Hidradenitis suppurativa: Signs and symptoms
- Psoriatic arthritis: Symptoms
- DailyMed - AZATHIOPRINE tablet
- Allopurinol – Life-threatening interaction with azathioprine or mercaptopurine
- Glucocorticoid-Induced Adrenal Insufficiency | Endocrine Society
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.